Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)

China flag China · Delayed Price · Currency is CNY
6.55
+0.11 (1.71%)
Jul 3, 2026, 3:04 PM CST
Market Cap5.43B -14.6%
Revenue (ttm)1.48B +5.6%
Net Income222.94M +9.4%
EPS0.27 +8.7%
Shares Out 828.87M
PE Ratio24.08
Forward PEn/a
Dividend0.09 (1.37%)
Ex-Dividend DateMay 29, 2026
Volume9,736,100
Open6.30
Previous Close6.44
Day's Range6.30 - 6.58
52-Week Range5.99 - 8.45
Beta0.14
Analystsn/a
Price Targetn/a
Earnings DateAug 27, 2026

About SHE:002349

Jinghua Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers active pharmaceutical ingredients (APIs) and intermediates, chemical and pharmaceutical intermediates, Chinese medicinal herbs and materials, health products, and Western medicine products. It also provides Jidesheng antivenomous tablets, Nantong Wang’s baby health pill, Ningning ZhengChaihu granules, Dachaihu granules, Gubenkechuan tablets, dizzine... [Read more]

Sector Healthcare
Founded 1957
Employees 1,462
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002349
Full Company Profile

Financial Performance

In 2025, SHE:002349's revenue was 1.46 billion, an increase of 4.13% compared to the previous year's 1.40 billion. Earnings were 219.28 million, an increase of 3.12%.

Financial Statements